News
Feed
Events
Feed
News
+ Events
Feed

Lonza Group AG

  • ISIN CH0013841017
  • Land Switzerland

Aktuelle News

1 November 2022

07:00 Corporate EN

Lonza Group AG

Corporate
EN

Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine

12 September 2022

07:00 Corporate EN

Lonza Group AG

Corporate
EN

Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division

6 September 2022

07:00 Corporate EN

Lonza Group AG

Corporate
EN

Lonza and Touchlight collaborate on end-to-end mRNA offering

22 Juli 2022

07:01 Ad-hoc

Lonza Group AG

Ad-hoc

Lonza erzielt im ersten Halbjahr 2022 ein solides Ergebnis mit einem Umsatzwachstum von 16.8% (kWk) und einer Kern-EBITDA-Marge von 33.1%

1 Juli 2022

08:00 Corporate EN

Lonza Group AG

Corporate
EN

Maria Soler Nunez appointed as Head, Group Operations

07:01 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)

26 Januar 2022

07:01 Ad-hoc

Lonza Group AG

Ad-hoc

Lonza erzielt ein starkes Ergebnis in 2021 mit 20% Umsatzwachstum (kWk)

07:00 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Lonza Delivers Strong 2021 performance with 20% CER Sales Growth

12 Oktober 2021

07:01 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Capital Markets Day 2021: Lonza to Capture Market Demand and Ensure Sustainable Value Creation Through Long-Term Growth

26 August 2021

07:00 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Philippe Deecke appointed as Chief Financial Officer of Lonza Group

23 Juli 2021

07:01 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Lonza Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3% CORE EBITDA Margin

16 Juli 2021

07:00 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply

2 Juli 2021

07:00 Corporate EN

Lonza Group AG

Corporate
EN

Lonza Completes Divestment of Specialty Ingredients Business

29 Juni 2021

07:01 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Lonza Publishes Restated Financials for 2020

2 Juni 2021

07:00 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands

6 Mai 2021

07:01 Ad-hoc EN

Lonza Group AG

Ad-hoc
EN

Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)

Anstehende Events

Keine Events gefunden